Show
Sort by
-
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response : a sub-study of the NEAT001/ANRS143 randomized trial
-
- Journal Article
- A1
- open access
Switching to doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) maintains HIV-1 virologic suppression through 48 weeks : results of the DRIVE-SHIFT trial
-
- Journal Article
- A1
- open access
Validation of a novel multivariate method of defining HIV-associated cognitive impairment
-
Beneficial impact of early treatment on restriction factor expression profile
-
Beneficial impact of early treatment on restriction factor expression profile
-
The expression profile of host restriction factors in different cohorts of HIV-1 infected patients
-
Beneficial impact of early treatment on restriction factor expression profile
-
- Journal Article
- A1
- open access
Disparities in HIV clinic care across Europe : findings from the EuroSIDA clinic survey
-
Aviremia 10-year post-ART discontinuation initiated at seroconversion
-
Impact of a decade of successful antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs